GL1X · GenesisL1 explorer

UniProt P35557

Isoform 2 of Hexokinase-4 (P35557)

Isoform 2 of Hexokinase-4 (UniProt P35557), EC 2.7.1.1, 2.7.1.2: 66 experimental structures on GenesisL1, 9 ligands bound, 28 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P35557
Protein
Isoform 2 of Hexokinase-4
EC
2.7.1.1, 2.7.1.2
Experimental structures
66
Predicted models
0
Ligands
9
Pockets
28 · 5 records with a druggable one

Structures

66 records of P35557 in the MolNFT archive: 66 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1V4SCrystal structure of human glucokinasex-ray diffractionA——
1V4SCrystal structure of human glucokinasex-ray diffractionA——
1V4TCrystal structure of human glucokinasex-ray diffractionA——
1V4TCrystal structure of human glucokinasex-ray diffractionA——
3A0IHuman glucokinase in complex with a synthetic activatorx-ray diffractionX——
3A0IHuman glucokinase in complex with a synthetic activatorx-ray diffractionX——
3F9MHuman pancreatic glucokinase in complex with glucose and activator showing a mobile flapx-ray diffractionA——
3F9MHuman pancreatic glucokinase in complex with glucose and activator showing a mobile flapx-ray diffractionA——
3FGUCatalytic complex of Human Glucokinasex-ray diffractionA——
3FGUCatalytic complex of human glucokinasex-ray diffractionA——
3FR0Human glucokinase in complex with 2-amino benzamide activatorx-ray diffractionA——
3FR0Human glucokinase in complex with 2-amino benzamide activatorx-ray diffractionA——
3H1VHuman glucokinase in complex with a synthetic activatorx-ray diffractionX——
3H1VHuman glucokinase in complex with a synthetic activatorx-ray diffractionX——
3ID8Ternary complex of human pancreatic glucokinase crystallized with activator, glucose and AMP-PNPx-ray diffractionA——
3ID8Ternary complex of human pancreatic glucokinase crystallized with activator, glucose and AMP-pnpx-ray diffractionA——
3IDHHuman pancreatic glucokinase in complex with glucosex-ray diffractionA——
3IDHHuman pancreatic glucokinase in complex with glucosex-ray diffractionA——
3QICThe structure of human glucokinase E339K mutationx-ray diffractionA——
3QICThe structure of human glucokinase E339K mutationx-ray diffractionA——
3S41Glucokinase in complex with activator and glucosex-ray diffractionA——
3S41Glucokinase in complex with activator and glucosex-ray diffractionA——
3VEVGlucokinase in complex with an activator and glucosex-ray diffractionA——
3VEVGlucokinase in complex with an activator and glucosex-ray diffractionA——
3VEYglucokinase in complex with glucose and ATPgSx-ray diffractionA——
3VEYGlucokinase in complex with glucose and atpgsx-ray diffractionA——
3VF6Glucokinase in complex with glucose and activatorx-ray diffractionA——
3VF6Glucokinase in complex with glucose and activatorx-ray diffractionA——
4DCHInsights into Glucokinase Activation Mechanism: Observation of Multiple Distinct Protein…x-ray diffractionA——
4DCHInsights into glucokinase activation mechanism: observation of multiple distinct protein…x-ray diffractionA——
4DHYCrystal structure of human glucokinase in complex with glucose and activatorx-ray diffractionA——
4DHYCrystal structure of human glucokinase in complex with glucose and activatorx-ray diffractionA——
4ISEHuman glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-(6-fluoro-4-oxoquinazolin-3(4H…x-ray diffractionA——
4ISEHuman glucokinase in complex with novel activator (2S)-3-cyclohexyl-2…x-ray diffractionA——
4ISFHuman glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-(6-fluoro-2,4-dioxo-1,4-dihydr…x-ray diffractionA——
4ISFHuman glucokinase in complex with novel activator (2S)-3-cyclohexyl-2…x-ray diffractionA——
4ISGHuman glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-[4-(methylsulfonyl)-2-oxopiper…x-ray diffractionA——
4ISGHuman glucokinase in complex with novel activator (2S)-3-cyclohexyl-2…x-ray diffractionA——
4IWVCrystals structure of Human Glucokinase in complex with small molecule activatorx-ray diffractionA——
4IWVCrystals structure of human glucokinase in complex with small molecule activatorx-ray diffractionA——
4IXCCrystal structure of Human Glucokinase in complex with a small molecule activator.x-ray diffractionA——
4IXCCrystal structure of human glucokinase in complex with a small molecule activator.x-ray diffractionA——
4L3QCrystal structure of glucokinase-activator complexx-ray diffractionA——
4L3QCrystal structure of glucokinase-activator complexx-ray diffractionA——
4LC9Structural Basis for Regulation of Human Glucokinase by Glucokinase Regulatory Proteinx-ray diffractionB——
4LC9Structural basis for regulation of human glucokinase by glucokinase regulatory proteinx-ray diffractionB——
4MLEHuman Glucokinase in Complex with Novel Amino Thiazole Activatorx-ray diffractionA——
4MLEHuman glucokinase in complex with novel amino thiazole activatorx-ray diffractionA——
4MLHHuman Glucokinase in Complex with a Novel Amino Thiazole Allosteric Activatorx-ray diffractionA——
4MLHHuman glucokinase in complex with a novel amino thiazole allosteric activatorx-ray diffractionA——
4NO7Human Glucokinase in complex with a nanomolar activator.x-ray diffractionA——
4NO7Human glucokinase in complex with a nanomolar activator.x-ray diffractionA——
4RCHDiscovery of 2-Pyridyl Ureas as Glucokinase Activatorsx-ray diffractionA——
4RCHDiscovery of 2-pyridyl ureas as glucokinase activatorsx-ray diffractionA——
5V4WHuman glucokinase in complex with novel indazole activator.x-ray diffractionAGLC, 8WM, IOD4 (best 0.64)
5V4WHuman glucokinase in complex with novel indazole activator.x-ray diffractionAGLC, 8WM, IOD—
5V4XHuman glucokinase in complex with novel pyrazole activator.x-ray diffractionAGLC, 8WJ, IOD3 (best 0.66)
5V4XHuman glucokinase in complex with novel pyrazole activator.x-ray diffractionAGLC, 8WJ, IOD—
6E0ECrystal structure of glucokinase in complex with compound 6x-ray diffractionAGLC, HKM—
6E0ICrystal structure of Glucokinase in complex with compound 72x-ray diffractionAGLC, HKG4 (best 0.56)

6 records more on the page itself.

Ligands

  • GLC · alpha-D-glucopyranose · in 11 records
  • IOD · Iodide ion · in 4 records
  • 8WJ · (2S)-3-cyclohexyl-2-[4-(cyclopentylsulfonyl)-2-oxopyridin-1(2H)-yl]-N-(1,3-thiazol-2-yl)propanamide · in 2 records
  • 8WM · (2S)-2-[4-(cyclopropylsulfonyl)-1H-indazol-1-yl]-N-(5-fluoro-1,3-thiazol-2-yl)-3-(oxan-4-yl)propanamide · in 2 records
  • G1S · diethyl {[3-(3-{[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy}-5-[(propan-2-yl)oxy]benzamido)-1H-pyrazol-1-yl]methyl}phosphonate · in 2 records
  • G2T · diethyl {[2-(3-[4-(methanesulfonyl)phenoxy]-5-{[(2S)-1-methoxypropan-2-yl]oxy}benzamido)-1,3-thiazol-4-yl]methyl}phosphonate · in 2 records
  • HKG · 1-{4-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-[(pyridin-2-yl)sulfanyl]pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]piperidin-1 -yl}ethan-1-one · in 2 records
  • NA · Sodium ion · in 2 records
  • HKM · 2-({2-[(4-methyl-1,3-thiazol-2-yl)amino]pyridin-3-yl}oxy)benzonitrile · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.